GW-6604 is an ALK5 inhibitor with an IC 50 value of 140 nM for inhibiting its autophosphorylation, and can be used in the study of liver fibrosis.
In Vitro
GW-6604 (0-10 μM, ) inhibits TGF-β-induced PAI-1 transcription and secretion in HepG2 cells with an IC 50 value of 500 nM, effectively blocking the Smad-dependent response. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
GW-6604(p.o., 25-80 mg/kg, twice a day, 3 weeks) dependently inhibits hepatic COL IA1 overexpression in an acute DMN model in SD rats, reducing its expression by 80%. Normal liver weight was maintained, liver fibrosis was effectively reduced and matrix degeneration was increased . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
规格
别名
2-苯基-4-[3-(吡啶-2-基)-1H-吡唑-4-基]吡啶
规格或纯度
≥98%
英文名称
GW-6604
生化机理
GW-6604 是一种 ALK5 抑制剂,抑制其自身磷酸化的 IC 50 值为 140 nM,可用于肝纤维化研究。